International Biotechnology (LON:IBT) Shares Cross Above Two Hundred Day Moving Average - Should You Sell?

International Biotechnology (LON:IBT - Get Free Report) passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 683.02 ($8.52) and traded as high as GBX 699.84 ($8.73). International Biotechnology shares last traded at GBX 692 ($8.63), with a volume of 53,428 shares trading hands.

International Biotechnology Trading Up 0.3 %

The company has a debt-to-equity ratio of 9.66, a quick ratio of 0.32 and a current ratio of 0.46. The company has a 50 day moving average of GBX 694.62 and a 200 day moving average of GBX 683.02. The stock has a market capitalization of £256.50 million, a price-to-earnings ratio of 1,445.83 and a beta of 0.21.

International Biotechnology Increases Dividend

The firm also recently declared a dividend, which will be paid on Friday, January 24th. Stockholders of record on Thursday, December 19th will be paid a GBX 15.56 ($0.19) dividend. This is an increase from International Biotechnology's previous dividend of $14.50. This represents a dividend yield of 2.21%. The ex-dividend date of this dividend is Thursday, December 19th. International Biotechnology's dividend payout ratio (DPR) is currently 6,041.67%.

Insider Buying and Selling

In related news, insider Katherine Cornish-Bowden acquired 1,500 shares of the stock in a transaction on Tuesday, December 17th. The shares were bought at an average price of GBX 713 ($8.89) per share, with a total value of £10,695 ($13,342.07). 4.18% of the stock is currently owned by company insiders.

International Biotechnology Company Profile

International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments.